Prudential Financial Inc Neurocrine Biosciences Inc Transaction History

Prudential Financial Inc

$80 Billion
Q3 2025

A detailed history of Prudential Financial Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Prudential Financial Inc holds 102,848 shares of NBIX stock, worth $14.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

102,848

Previous 145,330 29.23%

Holding current value

$14.9 Million

Previous $18.3 Million 20.96%

% of portfolio

0.02%

Previous 0.02%

39 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$123.98 - $146.67 $5.27 Million - $6.23 Million	-42,482 Reduced 29.23%	102,848 $14.4 Million
Q2 2025 Aug 12, 2025	BUY	$87.54 - $128.18 $2.28 Million - $3.34 Million	26,030 Added 21.82%	145,330 $18.3 Million
Q1 2025 May 13, 2025	SELL	$107.22 - $153.29 $9.74 Million - $13.9 Million	-90,875 Reduced 43.24%	119,300 $13.2 Million
Q4 2024 Feb 11, 2025	BUY	$111.62 - $139.44 $3.73 Million - $4.66 Million	33,450 Added 18.93%	210,175 $28.7 Million
Q3 2024 Nov 13, 2024	SELL	$114.58 - $153.15 $2.01 Million - $2.68 Million	-17,529 Reduced 9.02%	176,725 $20.3 Million

Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $10.2 Million - $11.2 Million	78,136 Added 67.29%	194,254 $26.7 Million
Q1 2024 May 14, 2024	SELL	$130.4 - $143.74 $27.8 Million - $30.7 Million	-213,253 Reduced 64.75%	116,118 $16 Million
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $5.33 Million - $6.67 Million	50,204 Added 17.98%	329,371 $43.4 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $18.2 Million - $22.6 Million	193,117 Added 224.42%	279,167 $31.4 Million
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $1.97 Million - $2.31 Million	21,980 Added 34.31%	86,050 $8.11 Million
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $865,153 - $1.13 Million	9,193 Added 16.75%	64,070 $6.49 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $557,825 - $664,142	5,227 Added 10.53%	54,877 $0
Q3 2022 Nov 04, 2022	BUY	$92.03 - $107.81 $1.84 Million - $2.16 Million	19,991 Added 67.4%	49,650 $5.15 Million
Q2 2022 Aug 15, 2022	SELL	$75.79 - $100.07 $2.36 Million - $3.12 Million	-31,192 Reduced 51.26%	29,659 $2.91 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $2.82 Million - $3.69 Million	38,962 Added 178.0%	60,851 $5.71 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $326,246 - $435,077	4,096 Added 23.02%	21,889 $2.03 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $476,575 - $547,635	-5,530 Reduced 23.71%	17,793 $1.72 Million
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $1.36 Million - $1.56 Million	-15,208 Reduced 39.47%	23,323 $2.27 Million
Q1 2021 May 12, 2021	SELL	$87.57 - $119.4 $2.45 Million - $3.35 Million	-28,016 Reduced 42.1%	38,531 $3.75 Million
Q4 2020 Feb 16, 2021	BUY	$86.91 - $108.33 $5.58 Million - $6.95 Million	64,186 Added 2718.59%	66,547 $6.38 Million
Q3 2020 Aug 05, 2021	SELL	$96.16 - $135.15 $7.25 Million - $10.2 Million	-75,381 Reduced 96.96%	2,361 $227,000
Q3 2020 Nov 16, 2020	BUY	$96.16 - $135.15 $7.27 Million - $10.2 Million	75,655 Added 3625.06%	77,742 $7.48 Million
Q2 2020 Aug 05, 2021	SELL	$85.09 - $130.36 $7.44 Million - $11.4 Million	-87,456 Reduced 97.67%	2,087 $255,000
Q2 2020 Aug 12, 2020	BUY	$85.09 - $130.36 $7.46 Million - $11.4 Million	87,649 Added 4627.72%	89,543 $10.9 Million
Q1 2020 Aug 05, 2021	SELL	$75.11 - $113.76 $3.93 Million - $5.95 Million	-52,269 Reduced 96.5%	1,894 $164,000
Q1 2020 May 12, 2020	BUY	$75.11 - $113.76 $3.96 Million - $6 Million	52,750 Added 3733.19%	54,163 $4.69 Million
Q4 2019 Aug 05, 2021	SELL	$86.8 - $118.57 $3.7 Million - $5.05 Million	-42,618 Reduced 96.79%	1,413 $152,000
Q4 2019 Feb 11, 2020	BUY	$86.8 - $118.57 $3.7 Million - $5.05 Million	42,627 Added 3036.11%	44,031 $4.73 Million
Q3 2019 Aug 05, 2021	SELL	$83.82 - $101.5 $3.48 Million - $4.21 Million	-41,466 Reduced 96.72%	1,404 $127,000
Q3 2019 Nov 13, 2019	BUY	$83.82 - $101.5 $3.49 Million - $4.22 Million	41,618 Added 3324.12%	42,870 $3.86 Million
Q2 2019 Aug 05, 2021	SELL	$72.24 - $91.27 $506,980 - $640,532	-7,018 Reduced 84.86%	1,252 $106,000
Q2 2019 Aug 08, 2019	BUY	$72.24 - $91.27 $510,447 - $644,913	7,066 Added 586.88%	8,270 $0
Q1 2019 Aug 05, 2021	SELL	$69.31 - $91.53 $784,311 - $1.04 Million	-11,316 Reduced 90.38%	1,204 $106,000
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $843,294 - $1.11 Million	12,167 Added 3446.74%	12,520 $0
Q4 2018 Aug 05, 2021	SELL	$68.32 - $124.36 $1.76 Million - $3.2 Million	-25,767 Reduced 98.65%	353 $25,000
Q4 2018 Feb 07, 2019	SELL	$68.32 - $124.36 $23,228 - $42,282	-340 Reduced 1.28%	26,120 $1.87 Million
Q3 2018 Nov 07, 2018	BUY	$98.88 - $125.85 $2.16 Million - $2.75 Million	21,890 Added 478.99%	26,460 $0
Q4 2017 Feb 13, 2018	SELL	$58.53 - $77.59 $40,971 - $54,313	-700 Reduced 13.28%	4,570 $355,000
Q3 2017 Nov 02, 2017	BUY	$47.97 - $61.28 $252,801 - $322,945	5,270	5,270 $323,000

Others Institutions Holding NBIX

# of Institutions

724

Shares Held

102M

Call Options Held

230K

Put Options Held

477K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Neurocrine Biosciences Inc Transaction History